Table 2 Outcomes of assisted reproduction treatment cycles after pretreatment with either GnRH agonist or Dienogest

Total dose of FSH (IU)^a

2047 ± 67.7

2180 ± 57.4

0.65

No. of oocyte^a

11.4 ± 1.2

11.1 ± 1.4

0.78

No. of mature oocytes^a

6.6 ± 1.3

6 ± 1.8

0.71

Fertilization rate (%) ^b

40.3%

47.67%

0.38

No. of transferrable embryos^a

4.5 ± 1.8

5.1 ± 2.1

0.63

 Cleavage stage

37 (55.22%)

42 (62.69%)

0.37

 Blastocyst stage

30 (44.78%)

25 (37.31%)

Pregnancy rate (%) ^b

15/67 (22.39%)

1 7/67 (25.37%)

0.69

Clinical pregnancy rate (%) ^b

12/67 (17.91%)

17/67 (25.37%)

0.29

Miscarriage rate (%) ^b

2/15 (13.3%)

0

–

Cost of pretreatment /ovarian stimulation (EGP)^a

3664 ± 45.1

2773 ± 38.1

< 0.001